|
| |
| | | 68009 | | 28.04.2022 | | NOBEL Pharma Schweiz AG | | | | | | | 27.04.2027 | | | | | | 60000. | | | | 06.03. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Rivaroxaban NOBEL 10 mg | Filmtabletten | Coated tablets (Rivaroxabanum 10 mg) | B01AF01 | CI | | 02 | Rivaroxaban NOBEL 15 mg | Filmtabletten | Coated tablets (Rivaroxabanum 15 mg) | B01AF01 | CI | | 03 | Rivaroxaban NOBEL 20 mg | Filmtabletten | Coated tablets (Rivaroxabanum 20 mg) | B01AF01 | CI |
|
|
|
